Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1992-8-26
|
pubmed:abstractText |
Twenty-six healthy volunteers received either 25 micrograms of cholecystokinin-tetrapeptide (CCK-4) or a mixture of 35% carbon dioxide in oxygen (CO2). DSM-III-R criteria including anxiety, apprehension and/or fear of at least moderate intensity were used to determine the occurrence of a panic attack. Results for the entire sample revealed that CCK-4 produced significantly more intense symptoms than CO2, but not a significantly greater number of symptoms. The incidence of DSM-III-R panic attacks was similar with both substances; 21% (3/14) for CO2 and 17% (2/12) for CCK-4. This study indicates that CCK-4 is at least as potent as CO2 in producing panic symptoms in healthy volunteers and is a useful challenge paradigm for comparative research of pharmacologic agents which possess distinct neurobiologic properties.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0924-977X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
137-41
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1821703-Adult,
pubmed-meshheading:1821703-Carbon Dioxide,
pubmed-meshheading:1821703-Female,
pubmed-meshheading:1821703-Humans,
pubmed-meshheading:1821703-Male,
pubmed-meshheading:1821703-Panic,
pubmed-meshheading:1821703-Psychiatric Status Rating Scales,
pubmed-meshheading:1821703-Tetragastrin
|
pubmed:year |
1991
|
pubmed:articleTitle |
Comparison of the effects of cholecystokinin-tetrapeptide and carbon dioxide in health volunteers.
|
pubmed:affiliation |
Department of Psychiatry, St. Mary's Hospital Centre, McGill University, Montreal, Quebec, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|